ALL IN

Welcome to the Brand page for “ALL IN”, which is offered here for The mark consists of a shaded circle, inside which is an arrow pointing to the right. to the right of the circle is the wording all in in capital letters.;color is not claimed as a feature of the mark.;promoting and raising public awareness of lupus nephritis;medical information services, providing information to patients on lupus nephritis; conducting medical studies for medical diagnostic or treatment purposes in the field of lupus nephritis; conducting patient studies in the nature of medical evaluation services, functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessing program effectiveness;research and development activities in the field of lupus nephritis; conducting medical studies in the nature of medical and scientific research in the field of lupus nephritis; conducting clinical studies in the nature of conducting research and clinical trials for others relating to therapeutic options and pharmaceuticals in the field of lupus nephritis; conducting patient studies in the nature of evaluating new pharmaceuticals to assess feasibility for use in the treatment of lupus nephritis;.

Its status is currently believed to be active. Its class is unavailable. “ALL IN” is believed to be currently owned by “AURINIA PHARMACEUTICALS INC.”

Owner:
AURINIA PHARMACEUTICALS INC.
Owner Details
Description:
The mark consists of a shaded circle, inside which is an arrow pointing to the right. To the right of the circle is the wording ALL IN in capital letters.;Color is not claimed as a feature of the mark.;Promoting and raising public awareness of lupus nephritis;Medical information services, providing information to patients on lupus nephritis; conducting medical studies for medical diagnostic or treatment purposes in the field of lupus nephritis; conducting patient studies in the nature of medical evaluation services, functional assessment programs for patients receiving medical therapy services for purposes of guiding treatment and assessing program effectiveness;Research and development activities in the field of lupus nephritis; conducting medical studies in the nature of medical and scientific research in the field of lupus nephritis; conducting clinical studies in the nature of conducting research and clinical trials for others relating to therapeutic options and pharmaceuticals in the field of lupus nephritis; conducting patient studies in the nature of evaluating new pharmaceuticals to assess feasibility for use in the treatment of lupus nephritis;
Categories: